Biohit, a biotechnology company, produces diagnostic tests and analysis systems for use in research institutions and healthcare industries worldwide. Its diagnostic tests product range includes the blood-sample based GastroPanel test for diagnosing diseases of the stomach and associated risks; quick tests for the diagnosis of lactose intolerance, Helicobacter pylori infection, and Celiac disease; and ColonView for the early detection of fecal occult blood. The Company's diagnostic tests are also used for the identification of patients at increased risk of gastric cancer, peptic ulcer disease, and gastroesophageal reflux disease, as well as deficiencies of vitamin B12, calcium, and iron.